Form 4 for MED MEDIFAST INC
Accepted 2023-03-14 00:00:00 ET · period of report 2023-03-10 · accession 0001628280-23-007912 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-03-14 | 2023-03-10 | MED | SCHLACKMAN SCOTT | Dir | M - OptEx | $27.68 | +2,200 | 9,480 | +30% | +$60.9K |
| D | 2023-03-14 | 2023-03-10 | MED | SCHLACKMAN SCOTT | Dir | S - Sale+OE | $108.68 | -2,200 | 7,280 | -23% | -$239.1K |
| D | 2023-03-14 | 2023-03-10 | MED | SCHLACKMAN SCOTT | Dir | M - OptEx | $0.00 | -2,200 | 1,300 | -63% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-10 | M | A | 2,200 | $27.68 | 9,480.09 | D | — | — | |
| 2 | Common | Common Stock | 2023-03-10 | S | D | 2,200 | $108.68 | 7,280.09 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2023-03-10 | M | D | 2,200 | $0.00 | 1,300 | D | $27.68 · — to 2026-02-04 | 2,200 Common Stock | (F1) The reporting person received 5,000 stock options on February 4, 2016 pursuant to the Medifast, Inc. Amended and Restated 2012 Share Incentive Plan. These options vested in three equal annual installments beginning on February 4, 2017. |